System ONE-M

System ONE-M is the new versatile enabler for dermatologic therapy, where high-accuracy treatments with high efficacy and low pain-level are key to clinical success. 

It serves as a new alternative or addition to lasers, PDT, cryosurgery, surgery, and various topical treatments, all of which entail high risks, low success rates, and significant pain for the patient. 

In addition to comparable or superior efficacy, patients and clinicians experience a range of advantages compared to other conventional methods: 

• • No radiation 
  • No surgery 
  • No fumes or smells 
  • No need for anesthesia 
  • No down-time after treatment 
  • Minimal risk of scarring
  • Minimal risk of dyspigmentation

System ONE-M is indicated for medical and aesthetic dermatological therapy: 

Medical indications:

• • Basal cell carcinoma
  • Actinic keratosis
  • Vascular hemangiomas and tumors of the skin
  • Cutaneous NF1 fibromas (cNF)
  • Verruca vulgaris (common warts)
  • Condylomata acuminata (genital warts)
  • Cystic acne and acne comedones
  • Seborrheic keratosis / Seborrheic warts
  • Superficial telangiectasia (spider veins)
  • Sebaceous hyperplasia
  • Other benign epidermal and cutaneous neoplasms of the human skin (e.g. hidrocystoma, Fox
    Fordyce Disease, Birt-Hogg Dubé syndrome, epidermal inclusion cysts, etc

Non-medical (aesthetic) conditions:

• • Vascular lesions (cherry spots and venous lakes)
  • Small acrochordons (skin tags)
  • Solar lentigines (liver spots)
  • Fine-line wrinkles
  • Removal of smaller tattoos and tattoos not responding to laser removal
  • Other aesthetic HIFU treatments of the human skin

__

TOOsonix products and technology are patent protected:

U.S. Patent No. 11,491,351;  U.S. Patent No. 11,679,283 and

EP3589367B1, CN109890463B. Other patents pending.